Image

Method for bAdge-dosi Monitoring of X-ray Exposure Values in Operating Theatre Surgery

Method for bAdge-dosi Monitoring of X-ray Exposure Values in Operating Theatre Surgery

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Surgical procedures involving X-rays in the operating room have increased in recent years, thereby increasing the exposure of operating room staff to ionizing radiation. An individual dosimeter makes it possible to record the radiation exposure to which these personnel are exposed. However, it has been noticed that these dosimeters are not thoroughly worn, consequently the radiation doses recorded are not reliable.

In order to increase the proportion of dosimeters systematically worn in the operating room, we study the impact of the association of the passive dosimeter with the hospital access badge (forming the Badge-Dosi). A first pilot study was carried out at Tours University Hospital showing the effectiveness of this concept. With the present study, we carry out a multicenter study. Our hypothesis is that the Badge-Dosi allows a significant increase of dosimeter use in the operating room, which improves the reliability of the monitoring of personnel.

Eligibility

Inclusion Criteria:

TEST group :

  • People working in the operating room at least 80% of the time (excluding people working less than 80% of the time).
  • Have been monitored by a delayed-reading dosimeter for at least 1 year.
  • Carry an access card (i.e. be the holder).

LIFE group :

  • Person working in the same centre as the people in the TEST group.
  • Person not exposed to radiation at their workstation
  • Holder of an access card

HOME group :

  • Person working in the same centre as people in the TEST Group and live near the center

Exclusion Criteria:

For all Groups :

  • Person objecting to data processing
  • Interns/externs/non-permanent staff likely to change jobs during the study period
  • Person who had a nuclear medicine examination within 15 days before the start of the study
  • Anyone who had internal vectorised therapy with iodine-131 or Lu-177 within 30 days before the start of the study.

Study details
    X-Ray

NCT06659939

University Hospital, Tours

9 June 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.